🇦🇪 Country Profile

United Arab Emirates

Fast-growing pharmaceutical trade with United Arab Emirates

🇦🇪 $374M
All data from DGCIS India export records (fiscal year, April–March).
$374M
Scale
United Arab Emirates' healthcare system receives $374M in Indian pharmaceutical products each year, affordable, quality medicine.
55%
Medicine
Primarily medicines (55%), supplemented by medicine ingredients and traditional & herbal.
3.8×
Trajectory
One of the faster-growing relationships, India's pharmaceutical supply to United Arab Emirates has expanded 3.8× over the decade.
Context
Part of India's pharmaceutical supply network across Middle East.
Impact
Indian pharmaceutical companies have both exported to and invested directly in United Arab Emirates, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $207M (55.4%) Medicine Ingredients $110M (29.5%) Traditional & Herbal $32.4M (8.7%) Surgical & Hospital Supplies $22.3M (6.0%) Vaccines $1.9M (0.5%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in United Arab Emirates Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into United Arab Emirates: $889M across 64 filings (2011-2026).